Clin Appl Thromb Hemost 2014 May;20(4):456-7
Next generation nanomedicine in the genesis of "Ankaferd blood stopper nanohemostat": a novel chimeric topical hemostatic agent for clinical hemorrhages.
Beyazit Y1, Huri E, Purnak T, Guler MO, Haznedaroglu IC.
href="/pubmed/?term=Beyazit%20Y%5BAuthor%5D&cauthor=true&cauthor_uid=24363214">Beyazit Y
1
,
Huri E
,
Purnak T
,
Guler MO
,
Haznedaroglu IC
.
Author information
1
1Department of Gastroenterology, Canakkale State Hospital, Canakkale, Turkey.
Comment on
Effects of Ankaferd Blood Stopper and Celox on the tissue factor activities of warfarin-treated rats.
[Clin Appl Thromb Hemost. 2014]
PMID:
24363214
[PubMed - indexed for MEDLINE]
Share
Publication Types, MeSH Terms, Substances
Publication Types
Comment
Letter
MeSH Terms
Animals
Biopolymers/pharmacology*
Male
Plant Extracts/pharmacology*
Thromboplastin/metabolism*
Warfarin/pharmacology*
Substances
Biopolymers
Plant Extracts
Warfarin
Thromboplastin
LinkOut - more resources
Full Text Sources
HighWire - PDF
Ovid Technologies, Inc.
Other Literature Sources
Access more work from the authors - ResearchGate
Medical
Blood Thinners - MedlinePlus Health Information
Miscellaneous
WARFARIN - Hazardous Substances Data Bank
PubMed Commons home
PubMed Commons
0
comments
How to join PubMed Commons
How to cite this comment:
Supplemental Content
Full text links
24363214[uid]
Search
See more...
You are here:
NCBI
>
Literature
> PubMed
Write to the Help Desk